文献速递妇科

子宫内膜活检DNA甲基化分析预测子宫内膜癌风险

Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2020-01-03

该研究纳入23例子宫内膜活检为良性(正常或增生)后发生子宫内膜癌的患者,按1:1匹配未发生癌的良性活检对照,采用焦磷酸测序检测4个基因26个CpG位点的甲基化百分比。结果显示ADCYAP1和HAND2基因平均甲基化事件在病例组显著高于对照组,AUC分别为0.71和0.83。

要点

  • 良性子宫内膜活检中ADCYAP1和HAND2甲基化升高与未来子宫内膜癌风险相关。
  • ADCYAP1和HAND2预测未来子宫内膜癌的AUC分别为0.71和0.83。
  • 所有4个基因的CpG位点甲基化百分比呈对照→病例→癌的一致升高趋势。

核心结论

  • 良性子宫内膜活检中特定DNA甲基化模式与未来子宫内膜癌发生相关。

研究设计与样本

  • 在Mayo Clinic识别23例良性子宫内膜活检(正常14例,增生9例)后中位1年发生子宫内膜癌的病例,按良性活检组织学、活检日期、活检时年龄和活检后随访时长1:1匹配未发生子宫内膜癌的良性活检对照。
  • 对石蜡包埋组织提取DNA行焦磷酸测序,检测4个基因(ADCYAP1、HAND2、MME、RASSF1A)26个启动子区CpG位点的甲基化百分比。

主要发现

  • 病理复核后确定23对匹配病例和对照(每组正常14例,无 atypia 增生9例)。
  • 病例组从良性活检到子宫内膜癌的中位时间为1年(范围2天至9.2年)。
  • 所有CpG位点从对照到病例到子宫内膜癌呈现甲基化百分比一致升高的趋势。
  • 基因水平上,病例组ADCYAP1和HAND2的平均甲基化事件显著高于对照组(p=0.015和p=0.021)。
  • ADCYAP1和HAND2预测良性活检后未来发生子宫内膜癌的AUC分别为0.71(95%CI 0.55-0.88)和0.83(95%CI 0.64-1)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether analysis of methylated DNA in benign endometrial biopsy (EB) specimens is associated with risk of endometrial cancer (EC). METHODS: We identified 23 women with EBs performed at Mayo Clinic diagnosed as normal (n = 14) or hyperplasia (n = 9) and who later developed endometrial cancer after a median interval of 1 year. Cases were matched 1:1 with patients with benign EBs who did not develop EC (controls) by histology of benign EB (normal endometrium vs. endometrial hyperplasia without atypia), date of EB, age at EB, and length of post-biopsy follow-up. DNA extracted from formalin-fixed paraffin-embedded tissues underwent pyrosequencing to determine percent methylation of promoter region CpGs at 26 loci in 4 genes (ADCYAP1, HAND2, MME, RASSF1A) previously reported as methylated in EC. RESULTS: After pathologic review, 23 matched pairs of cases and controls were identified (14 normal, 9 hyperplasia without atypia per group). Among cases, median time from benign EB to EC was 1 year (range 2 days - 9.2 years). We evaluated 26 CpG sites within 4 genes and found a consistent trend of increasing percentage of methylation from control to case to EC for all CpGs. At the gene-level, mean methylation events of ADCYAP1 and HAND2 in cases were significantly higher than control (p = 0.015 and p = 0.021, respectively). Though the other genes did not reach statistical significance, we observed an increased methylation trend among all genes. Area-under-curve (AUC) calculations (predicting future development of EC in the setting of benign EB) for ADCYAP1 and HAND2 were 0.71 (95% CI 0.55-0.88) and 0.83 (95% CI 0.64-1, respectively). CONCLUSIONS: This proof-of-principle study provides evidence that specific methylation patterns in benign EB correlate with future development of EC.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Multinu F, Chen J, Madison JD, et al. Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer. Gynecol Oncol. 2020. PMID: 31902687. doi:10.1016/j.ygyno.2019.12.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。